Adline Chem Lab
BSE: ADLINE · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Adline Chem Lab's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Adline Chem Lab Limited is an Indian company engaged in the manufacturing, trading, and distribution of chemical compounds, pharmaceutical raw materials, and laboratory reagents. It maintains a niche presence by serving industrial laboratories, research institutions, and healthcare manufacturers.
Business Model
The company generates revenue through the supply chain management of specialty chemicals and pharmaceutical inputs. Its model focuses on domestic distribution to institutional and industrial clients.
Management Commentary
Management is currently focused on stabilising operations and refining the company's business strategy following historical structural changes. The firm aims to strengthen its footprint within the Indian chemical distribution network.
Growth Outlook
Growth is expected to be driven by the expansion of the company's domestic distribution network and a focus on its niche specialty chemicals segment. Future performance remains contingent on successful operational stabilisation.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent environmental and safety regulations governing the chemical and pharmaceutical manufacturing sectors in India.
- Market Competition. As a small-scale player, the company faces intense competition from larger, more established chemical manufacturers and distributors.
- Operational Volatility. Historical management shifts and structural changes may lead to ongoing instability in business execution and strategic direction.
- Supply Chain Disruptions. Fluctuations in the availability and cost of raw materials could adversely impact the company's trading and distribution margins.
Start your research today
Unlock AI insights, financials, peers and live data on Adline Chem Lab and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Adline Chem LabADLINE | ₹7 Cr | — | — | — | — | — | — | — |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Adline Chem Lab
BSE: ADLINE · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Adline Chem Lab's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Adline Chem Lab Limited is an Indian company engaged in the manufacturing, trading, and distribution of chemical compounds, pharmaceutical raw materials, and laboratory reagents. It maintains a niche presence by serving industrial laboratories, research institutions, and healthcare manufacturers.
Business Model
The company generates revenue through the supply chain management of specialty chemicals and pharmaceutical inputs. Its model focuses on domestic distribution to institutional and industrial clients.
Management Commentary
Management is currently focused on stabilising operations and refining the company's business strategy following historical structural changes. The firm aims to strengthen its footprint within the Indian chemical distribution network.
Growth Outlook
Growth is expected to be driven by the expansion of the company's domestic distribution network and a focus on its niche specialty chemicals segment. Future performance remains contingent on successful operational stabilisation.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent environmental and safety regulations governing the chemical and pharmaceutical manufacturing sectors in India.
- Market Competition. As a small-scale player, the company faces intense competition from larger, more established chemical manufacturers and distributors.
- Operational Volatility. Historical management shifts and structural changes may lead to ongoing instability in business execution and strategic direction.
- Supply Chain Disruptions. Fluctuations in the availability and cost of raw materials could adversely impact the company's trading and distribution margins.
Start your research today
Unlock AI insights, financials, peers and live data on Adline Chem Lab and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026